Use of Pharmacoeconomics in Prescribing Research. Part 3: Cost-effectiveness Analysis--a Technique for Decision-making at the Margin

Overview

Journal J Clin Pharm Ther

Specialties Pharmacology
Pharmacy

Date 2003 Jun 11

PMID 12795784

Citations 2

Authors

R Lopert

D L Lang

S R Hill

Affiliations

Soon will be listed here.

Abstract

This is the third Research Note addressing pharmacoeconomics in prescribing research, reflecting the increasing use of economic evaluation in drug purchasing decisions in a variety of settings. In this segment we provide an overview of the theoretical basis, practical application and methodological limitations of cost-effectiveness analysis (CEA).

Citing Articles

Pharmacoeconomic Assessment of Antiallergic Drugs by Comparing Serum Immunoglobulin E Level as a Diagnostic and Monitoring Indicator of Allergic Rhinitis in Rural Population of India.

Pentewar G, Parab S Indian J Otolaryngol Head Neck Surg. 2023; 75(Suppl 1):928-933.

PMID: 37206771 PMC: 10188763. DOI: 10.1007/s12070-023-03488-9.

Efficacy of Generic Granisetron vs Kytril® for PONV in Major Gynecological Operations: A Randomized, Double-blind Clinical Trial.

Aleyasin A, Hanafi S, Saffarieh E, Torkamandi H, Allahyari S, Sadeghi F Iran J Pharm Res. 2013; 11(4):1059-64.

PMID: 24250537 PMC: 3813164.